Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis.

Arthritis care & research

Volumn 65, Issue 3, 2013, Pages 476-480

  Ribeiro, Ana C ^a   Laurindo, Ieda M ^b   Guedes, Lissiane K ^b   Saad, Carla G ^b   Moraes, Julio C ^b   Silva, Clóvis A ^b   Bonfa, Eloisa ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; ANTIRHEUMATIC AGENT; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; MALE; MIDDLE AGED; PANDEMIC; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MALE; MIDDLE AGED; PANDEMICS; PROSPECTIVE STUDIES;

EID: 84876323608     PISSN: None     EISSN: 21514658     Source Type: None    
DOI: 10.1002/acr.21838     Document Type: Article

References (0)